As the US FDA moves towards issuing final guidelines on biosimilars, recent research with specialists in five main therapy areas suggests they are willing to embrace them if efficacy and safety
This month, Daniel Ghinn examines a 'ground-breaking' multichannel campaign from Pfizer, which puts engagement and trust-building ahead of pushing products and allows the company to push the bo
Victor Ambros and Gary Ruvkun have shared this year's Nobel Prize in Physiology or Medicine for their discovery of microRNA, a class of RNA molecules that play a crucial role in gene regula
